Roles in cell-to-cell fusion of two conserved hydrophobic regions in the murine coronavirus spike protein

Virology

Volumn 244, Issue 2, 1998, Pages 483-494

  Luo, Zongli ^a   Weiss, Susan R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL FUSION; CELL MATURATION; CORONAVIRUS; GENETIC CONSERVATION; HYDROPHOBICITY; MEMBRANE FUSION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; SITE DIRECTED MUTAGENESIS; VIRUS TRANSMISSION;

ANIMALIA; CORONAVIRUS; MURINAE; MURINE HEPATITIS VIRUS; MURINE HEPATITIS VIRUS (STRAIN S); RNA VIRUSES;

EID: 0032503238     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9121     Document Type: Article

References (49)

1. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., Struhl K. Current Protocols in Molecular Biology. 1989;Greene and Wiley-Interscience, New York.
2. Binns M. M., Boursnell M. E., Tomley F. M., Brown D. K. Comparison of the spike precursor sequences of coronavirus IBV strains M41 and 6/82 with that of IBV Beaudette. J. Gen. Virol. 67:1986;2825-2831.
3. Boireau P., Cruciere C., Laporte J. Nucleotide sequence of the glycoprotein S gene of bovine enteric coronavirus and comparison with the S proteins of two mouse hepatitis virus strains. J. Gen. Virol. 71:1990;487-492.
4. Bos E. C. W., Heunen L., Luytjes W., Spaan W. J. M. Mutational analysis of the murine coronavirus spike protein: effect on cell-to-cell fusion. Virology. 214:1995;453-463.
5. Britton P. Coronavirus motif. Nature. 353:1991;394.
6. Buckland R., Malvoisin E., Beauverger P., Wild F. A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J. Gen. Virol. 73:1992;1703-1707.
7. Cavanagh D. Coronavirus IBV: Structural characterization of the spike protein. J. Gen. Virol. 64:1983;2577-2583.
8. Cavanagh D. The coronavirus surface glycoprotein. The Coronaviridae. 1995;Plenum, New York. p. 73-113.
9. Cavanagh D., Davis P. J., Darbyshire J. H., Peters R. W. Coronavirus IBV: Virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or hemagglutination-inhibiting antibody, or induce chicken tracheal protection. J. Gen. Virol. 67:1986;1435-1442.
10. Chamberlain J. P. Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate. Anal. Biochem. 98:1979;132-135.
11. Chambers P., Pringle C. R., Easton A. J. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol. 71:1990;3075-3080.
12. Chen C. M., Pocock D. H., Britton P. Genomic organization of a virulent Taiwanese strain of transmissible gastroenteritis virus. Adv. Exp. Med. Biol. 342:1993;23-28.
13. Cohen C., Parry D. A. Alpha helical coiled coils - A widespread motif in proteins. Trends Biochem. Sci. 11:1986;245-248.
14. Collins A. R., Knobler R. L., Powell H., Buchmeier M. J. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology. 119:1982;358-371.
15. de Groot R. J., Luytjes W., Horzinek M. C., van der Zeijst B. A., Spaan W. J., Lenstra J. A. Evidence for a coiled-coil structure in the spike proteins of coronaviruses. J. Mol. Biol. 196:1987a;963-966.
16. de Groot R. J., Maduro J., Lenstra J. A., Horzinek M. C., van der Zeijst B. A., Spaan W. J. cDNA cloning and sequence analysis of the gene encoding the peplomer protein of feline infectious peritonitis virus. J. Gen. Virol. 68:1987b;2639-2646.
17. de Groot R. J., Van Leen R. W., Dalderup M. J., Vennema H., Horzinek M. C., Spaan W. J. Stably expressed FIPV peplomer protein induces cell fusion and elicits neutralizing antibodies in mice. Virology. 171:1989;493-502.
18. DeGrado W. F. Peptide engineering: Catalytic molten globules. Nature. 365:1993;488-489.
19. Delahunty M. D., Rhee I., Freed E. O., Bonifacino J. S. Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: Identification of critical glycine residues. Virology. 218:1996;94-102.
20. Dempsey C. E. The actions of melittin on membranes. Biochim. Biophys. Acta. 1031:1990;143-161.
21. Doms R. W., Lamb R. A., Rose J. K., Helenius A. Folding and assembly of viral membrane proteins. Virology. 193:1993;545-562.
22. Dubay J. W., Roberts S. J., Brody B., Hunter E. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J. Virol. 66:1992;4748-4756.
23. Frana M. F., Behnke J. N., Sturman L. S., Holmes K. V. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: Host-dependent differences in proteolytic cleavage and cell fusion. J. Virol. 56:1985;912-920.
24. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
25. Gallagher T. M. Murine coronavirus membrane fusion is blocked by modification of thiols buried within the spike protein. J. Virol. 70:1996;4683-4690.
26. Harter C., James P., Bachi T., Semenza G., Brunner J. Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the "fusion peptide" J. Biol. Chem. 264:1989;6459-6464.
27. Higgins D. G., Bleasby A. J., Fuchs R. CLUSTAL V: Improved software for multiple sequence alignment. Comput. Appl. Biosci. 8:1992;189-191.
28. Horth M., Lambrecht B., Khim M. C., Bex F., Thiriart C., Ruysschaert J. M., Burny A., Brasseur R. Theoretical and functional analysis of the SIV fusion peptide. EMBO J. 10:1991;2747-2755.
29. Kornfeld R., Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 54:1985;631-664.
30. Kubo H., Yamada Y. K., Taguchi F. Localization of neutralizing epitopes and the receptor-binding site within the amino-terminal 330 amino acids of the murine coronavirus spike protein. J. Virol. 68:1994;5403-5410.
31. Luneberg J., Martin I., Nussler F., Ruysschaert J. M., Herrmann A. Structure and topology of the influenza virus fusion peptide in lipid bilayers. J. Biol. Chem. 270:1995;27606-27614.
32. Luytjes W., Gerritsma H., Bos E., Spaan W. Characterization of two temperature-sensitive mutants of coronavirus mouse hepatitis virus strain A59 with maturation defects in the spike protein. J. Virol. 71:1997;949-955.
33. Luytjes W., Sturman L. S., Bredenbeek P. J., Charite J., van d., Zeijst B. A., Horzinek M. C., Spaan W. J. Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology. 161:1987;479-487.
34. Marquardt T., Helenius A. Misfolding and aggregation of newly synthesized proteins in the endoplasmic reticulum. J. Cell Biol. 117:1992;505-513.
35. Muga A., Neugebauer W., Hirama T., Surewicz W. K. Membrane interaction and conformational properties of the putative fusion peptide of PH-30, a protein active in sperm-egg fusion. Biochemistry. 33:1994;4444-4448.
36. Nieva J. L., Nir S., Muga A., Goni F. M., Wilschut J. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: Different structural requirements for fusion and leakage. Biochemistry. 33:1994;3201-3209.
37. Nussbaum O., Broder C. C., Berger E. A. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:1994;5411-5422.
38. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
39. Segrest J. P., De L. H., Dohlman J. G., Brouillette C. G., Anantharamaiah G. M. Amphipathic helix motif: Classes and properties. Proteins. 8:1990;103-117.
40. Segrest J. P., Jones M. K., De L. H., Brouillette C. G., Venkatachalapathi Y. V., Anantharamaiah G. M. The amphipathic helix in the exchangeable apolipoproteins: A review of secondary structure and function. J. Lipid Res. 33:1992;141-166.
41. Sergel-Germano T., McQuain C., Morrison T. Muta-tions in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J. Virol. 68:1994;7654-7658.
42. Siddell S., Wege H., Ter Meulen V. The biology of coronaviruses. J. Gen. Virol. 64:1983;761-776.
43. Spaan W., Cavanagh D., Horzinek M. C. Coronaviruses: Structure and genome expression. J. Gen. Virol. 69:1988;2939-2952.
44. Sturman L. S., Ricard C. S., Holmes K. V. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: Activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J. Virol. 56:1985;904-911.
45. Taguchi F. The S2 subunit of the murine coronavirus spike protein is not involved in receptor binding. J. Virol. 69:1995;7260-7263.
46. Vennema H., Heijnen L., Zijderveld A., Horzinek M. C., Spaan W. J. Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. J. Virol. 64:1990;339-346.
47. White J. M. Viral and cellular membrane fusion proteins. Annu. Rev. Physiol. 52:1990;675-697.
48. White J. M. Membrane fusion. Science. 258:1992;917-924.
49. Yu Y. G., King D. S., Shin Y. K. Insertion of a coiled-coil peptide from influenza virus hemagglutinin into membranes. Science. 266:1994;274-276.